From President Mittelman

Integrating with Drexel will also benefit our faculty, offering the potential for significantly enhanced professional development and research support opportunities, access to state-of-the-art facilities and a chance to teach with the benefit of Drexel’s incredible technology infrastructure. The merger will bring together the strengths of both institutions in graduate health sciences, including Drexel’s medical, biomedical, public health, nursing and health professions, and our Optometry, Audiology, Biomedicine, Blindness and Low Vision Studies, Physician Assistant Studies, Occupational Therapy, Speech-Language Pathology and Orthotics and Prosthetics programs. We are confident there is no better partner to help us operationalize our mission: Advancing integrated healthcare through innovative education, research and clinical services.

As we move forward, we remain proud of our Salus legacy. Our agreement preserves the individual — and highly esteemed — Pennsylvania College of Optometry (PCO) and George S. Osborne brands, as well as continued economic support of our academic programs. Similarly, previous donations and existing endowments to specific programs will be honored. All unrestricted funds received by PCO and Salus prior to the merger will be restricted solely for the benefit of Salus University and PCO’s legacy programs. Going forward, donors will have the option of restricting their gifts to Salus legacy programs of their choosing.

I hope you join me in supporting this exciting new chapter in the Salus legacy, and that you will continue to support our future students. Should you have any questions or wish to share your thoughts, please don’t hesitate to be in touch with me or with Jacquie Patterson, Vice President for Institutional Advancement. Thanks for your continued support.

Best,

Michael H. Mittelman, OD ’80, MPH, MBA, FAAO, FACHE